CRSPCRISPR Therapeutics AG同业对比
CRISPR Therapeutics AG 与ARK Innovation ETF 持仓的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:ARKK 前十大持仓| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRSP本股 | $5.0B#14 | — | 2.8x#3 | 1415.8x#14 | -90.6%#14 | -58.8%#13 | -18933.6%#14 | -33.3%#13 | -32.6%#7 | — | -15.9%#7 | — |
| TSLA | $1.58T#2 | 438.6x#7 | 17.7x#12 | 16.6x#7 | -2.9%#13 | -46.1%#11 | 4.6%#7 | 4.3%#7 | 4.3%#5 | 5#2 | -9.3%#6 | — |
| TEM | $13M#15 | — | 0.0x#1 | 0.0x#1 | 83.4%#3 | 65.3%#4 | -19.9%#10 | -55.1%#14 | — | — | -16.3%#8 | — |
| SPCX | $986.8B#3 | — | 5.6x#6 | — | — | — | — | 0.0%#8 | — | — | — | — |
| SHOP | $204.6B#6 | 106.4x#4 | 16.1x#11 | 17.7x#9 | 30.1%#8 | -39.0%#10 | 12.7%#4 | 9.7%#4 | — | — | -9.3%#5 | — |
| COIN | $37.9B#8 | — | 2.7x#2 | 5.3x#3 | 9.4%#11 | -50.0%#12 | 20.0%#3 | 9.3%#5 | 9.9%#2 | — | — | — |
| AMD | $824.7B#4 | 129.5x#5 | 12.3x#10 | 23.8x#10 | 34.3%#7 | 164.2%#2 | 10.7%#6 | 6.4%#6 | 5.7%#4 | 8#1 | 98.2%#2 | — |
| CRCL | $17.9B#11 | 14.5x#1 | 5.1x#5 | 162.6x#13 | 624.0%#1 | -144.7%#14 | -87.8%#13 | -2.0%#9 | — | — | — | — |
| HOOD | $76.4B#7 | 39.2x#3 | 8.9x#8 | 17.1x#8 | 51.6%#5 | 33.5%#6 | 47.1%#1 | 22.0%#1 | 34.9%#1 | — | — | — |
| TWST | $9.6B#12 | — | 21.5x#13 | 25.4x#11 | 20.3%#9 | 62.8%#5 | -36.2%#12 | -17.4%#11 | -41.4%#8 | — | 388.5%#1 | — |
| TXG | $9.0B#13 | — | 10.8x#9 | 13.9x#6 | 5.2%#12 | 76.2%#3 | -9.5%#9 | -5.3%#10 | — | — | — | — |
| PLTR | $442.4B#5 | 157.4x#6 | 45.3x#14 | 98.8x#12 | 56.2%#4 | 251.6%#1 | 31.6%#2 | 16.6%#3 | — | — | -5.4%#4 | — |
| AMZN | $2.60T#1 | 19.4x#2 | 4.2x#4 | 3.6x#2 | 12.4%#10 | -0.4%#7 | 11.2%#5 | 22.0%#2 | 8.8%#3 | 4#3 | 7.9%#3 | — |
| RBLX | $30.8B#9 | — | — | 6.3x#5 | 35.8%#6 | -13.9%#8 | -25.2%#11 | — | — | — | — | — |
| CRWV | $29.6B#10 | — | 5.9x#7 | 5.8x#4 | 167.9%#2 | -35.3%#9 | -0.9%#8 | -23.2%#12 | -0.2%#6 | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-01。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议